ACCESSION: MSBNK-SMB_Measured-HSA015P0103008
RECORD_TITLE: Characterized; N-nitrosodiethylamine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 16
COMMENT: RAW_SPEC {'EL14_pos_2308': {'bp': 1906221.0, 'sum': 3294272.0}, 'EL20_pos_2302': {'bp': 1800086.0, 'sum': 3078087.0}, 'EL22_pos_2321': {'bp': 1792418.0, 'sum': 3081446.0}, 'EL18_pos_2313': {'bp': 1730067.0, 'sum': 2973811.0}, 'EL17_pos_2307': {'bp': 1638049.0, 'sum': 2841344.0}, 'EL23_pos_2313': {'bp': 1625374.0, 'sum': 2829429.0}, 'EL01_pos_2308': {'bp': 1615191.0, 'sum': 2786241.0}, 'EL08_pos_2308': {'bp': 1605245.0, 'sum': 2758975.0}, 'EL21_pos_2309': {'bp': 1466332.0, 'sum': 2592448.0}, 'EL15_pos_2314': {'bp': 1461754.0, 'sum': 2532955.0}, 'EL02_pos_2314': {'bp': 1452494.0, 'sum': 2585378.0}, 'EL04_pos_2327': {'bp': 1444526.0, 'sum': 2578574.0}, 'EL19_pos_2332': {'bp': 1410827.0, 'sum': 2495606.0}, 'EL10_pos_2319': {'bp': 1306466.0, 'sum': 2396385.0}, 'EL12_pos_2314': {'bp': 1250826.0, 'sum': 2228724.0}, 'EL13_pos_2315': {'bp': 1200422.0, 'sum': 2092767.0}}
COMMENT: RETENTION_TIME_STDEV 0.013
COMMENT: PRECURSOR_M/Z_RAW 103.087067
COMMENT: PRECURSOR_M/Z_STDEV 0.000032
COMMENT: PRECURSOR_IN_MS1 mz 103.086566; int 39.268; delta(ppm) 0.806117
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.225; C4H10N2O; [M+H]+; delta(ppm) -0.225315
COMMENT: PROPOSED_MF MS-FINDER 3.088; C4H10N2O; [M+H]+; delta(ppm) -0.226874
COMMENT: PROPOSED_MF SIRIUS5_Sirius 13.337; C4H10N2O; [M+H]+; delta(ppm) -0.226874
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H10N2O; [M+H]+; delta(ppm) -0.226874
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.596; C4H10N2O; [M+H]+; delta(ppm) -0.226874
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.005; C2H8N5; [M+H]+; delta(ppm) 12.797912
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H10N2O; [M+H]+; delta(ppm) -0.226874
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.738; WKJOQYHMXRVQDK-UHFFFAOYSA-N; [M+H]+; O=C(N)CN(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.422; ZQZJKHIIQFPZCS-UHFFFAOYSA-N; [M+H]+; CCCNC(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.222; LZMATGARSSLFMQ-UHFFFAOYSA-N; [M+H]+; CC(C)NC(N)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.182; WBNQDOYYEUMPFS-UHFFFAOYSA-N; [M+H]+; CCN(CC)N=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; YNHNXXYVCYCNJQ-UHFFFAOYSA-N; [M+H]+; C1COCCNN1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.546; WBNQDOYYEUMPFS-UHFFFAOYSA-N; [M+H]+; N-nitrosodiethylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.442; DAKZISABEDGGSV-UHFFFAOYSA-N; [M+H]+; UNPD107559
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.442; LZMATGARSSLFMQ-UHFFFAOYSA-N; [M+H]+; UNPD95988
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.390; YNHNXXYVCYCNJQ-UHFFFAOYSA-N; [M+H]+; 1,4,5-oxadiazepane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.390; ZQZJKHIIQFPZCS-UHFFFAOYSA-N; [M+H]+; propylurea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.390; WKJOQYHMXRVQDK-UHFFFAOYSA-N; [M+H]+; 2-(dimethylamino)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WBNQDOYYEUMPFS-UHFFFAOYSA-N; [M+H]+; N-nitrosodiethylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.330; LZMATGARSSLFMQ-UHFFFAOYSA-N; [M+H]+; UNPD95988
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.330; ZQZJKHIIQFPZCS-UHFFFAOYSA-N; [M+H]+; propylurea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.317; WKJOQYHMXRVQDK-UHFFFAOYSA-N; [M+H]+; 2-(dimethylamino)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.249; DAKZISABEDGGSV-UHFFFAOYSA-N; [M+H]+; UNPD107559
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; YNHNXXYVCYCNJQ-UHFFFAOYSA-N; [M+H]+; 1,4,5-oxadiazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.218; WBNQDOYYEUMPFS-UHFFFAOYSA-N; [M+H]+; N,N-diethylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.523; MKQLBNJQQZRQJU-UHFFFAOYSA-N; [M+H]+; morpholin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.287; ITBDKUCVKYSWMF-UHFFFAOYSA-N; [M+H]+; N-methyl-N-propylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; KQDYNYCCEGQPTN-UHFFFAOYSA-N; [M+H]+; N-methyl-N-propan-2-ylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.041; ZQZJKHIIQFPZCS-UHFFFAOYSA-N; [M+H]+; propylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.900; LZMATGARSSLFMQ-UHFFFAOYSA-N; [M+H]+; propan-2-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; WCVPFJVXEXJFLB-UHFFFAOYSA-N; [M+H]+; 4-aminobutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.766; DAKZISABEDGGSV-UHFFFAOYSA-N; [M+H]+; N-(2-aminoethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.716; SZOHWYCBDJPVGO-UHFFFAOYSA-N; [M+H]+; ethyl-ethylimino-oxidoazanium
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.595; WKJOQYHMXRVQDK-UHFFFAOYSA-N; [M+H]+; 2-(dimethylamino)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.555; JHRDEHLFNLLCQS-UHFFFAOYSA-N; [M+H]+; N'-hydroxy-2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.552; HNNJFUDLLWOVKZ-VKHMYHEASA-N; [M+H]+; (2S)-2-aminobutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.530; ZIOBGZDFMKCKGZ-UHFFFAOYSA-N; [M+H]+; 2-amino-2-methylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.502; QKNFFJHHPCWXTH-GSVOUGTGSA-N; [M+H]+; (2R)-2-(methylamino)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.487; FFJLSBFLTYYWII-UHFFFAOYSA-N; [M+H]+; 3-(methylamino)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.481; OTVXVVYHNZUDSN-UHFFFAOYSA-N; [M+H]+; 3-aminobutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.480; SNFFHBJWQFQMBC-UHFFFAOYSA-N; [M+H]+; 2-(ethylamino)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.470; PLNNJQXIITYYTN-UHFFFAOYSA-N; [M+H]+; 2-methylpropanehydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.469; OPENCMFJZQABIY-UHFFFAOYSA-N; [M+H]+; N'-hydroxybutanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.448; COSWCAGTKRUTQV-UHFFFAOYSA-N; [M+H]+; 1,1,3-trimethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.423; KNVRBEGQERGQRP-UHFFFAOYSA-N; [M+H]+; 2-amino-N,N-dimethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.419; QCQZFSUBYDWVBG-UHFFFAOYSA-N; [M+H]+; 2-amino-N-ethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.411; CKQYFZPCICOPMQ-UHFFFAOYSA-N; [M+H]+; 2-amino-N-methylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.410; BFJOJIJWHRDGQO-UHFFFAOYSA-N; [M+H]+; 3-amino-N-methylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.402; BXAIQPPVOCFPQA-UHFFFAOYSA-N; [M+H]+; 1-aminopyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.396; FGGKESDTDWWERY-UHFFFAOYSA-N; [M+H]+; 4-hydroxybutanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.390; KUFLBKOBMGLOKO-UHFFFAOYSA-N; [M+H]+; oxolan-3-ylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.387; VPSJSRRUXSUNFA-QWWZWVQMSA-N; [M+H]+; (3S,4S)-oxolane-3,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.387; ODANWMOQWMHGCY-UHFFFAOYSA-N; [M+H]+; 1,4-diaminobutan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.383; FCCCRBDJBTVFSJ-UHFFFAOYSA-N; [M+H]+; butanehydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.383; QFDYDSLVRDKIBH-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-N'-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.380; ZCZJKVCIYONNJR-QWWZWVQMSA-N; [M+H]+; (3R,4R)-4-aminopyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.367; IABRWXCXQSTUSS-UHFFFAOYSA-N; [M+H]+; 1-ethyl-3-methylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.304; NODGJSNKUCVLNN-UHFFFAOYSA-N; [M+H]+; N-methyl-2-(methylamino)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.293; GOLODWMXGLKPFT-UHFFFAOYSA-N; [M+H]+; 3-methoxypropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.285; ITEDVEJYKUPNNY-UHFFFAOYSA-N; [M+H]+; 2-methoxypropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.263; HVCIFMASZMODAI-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.161; UIWVQFSAXYWENY-UHFFFAOYSA-N; [M+H]+; N'-ethylacetohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.158; SLIKWWJXVUHCPJ-UHFFFAOYSA-N; [M+H]+; N',N'-dimethylacetohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.150; TXJURWDJHWXLSC-UHFFFAOYSA-N; [M+H]+; 2-ethoxyethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.147; YNHNXXYVCYCNJQ-UHFFFAOYSA-N; [M+H]+; 1,4,5-oxadiazepane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -47.854; WKJOQYHMXRVQDK; [M+H]+; 2-dimethylaminoacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -58.626; SLIKWWJXVUHCPJ; [M+H]+; N,N-Dimethylacetohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -77.120; UIWVQFSAXYWENY; [M+H]+; 1-Aethyl-2-acetylhydrazid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -82.225; WBNQDOYYEUMPFS; [M+H]+; DEN (mutagen)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -85.423; ITBDKUCVKYSWMF; [M+H]+; Methylpropylnitrosamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -87.177; QKNFFJHHPCWXTH; [M+H]+; Ambcb4031071
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -89.091; NODGJSNKUCVLNN; [M+H]+; N1,N2-Dimethylglycinamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -89.830; DAKZISABEDGGSV; [M+H]+; 2-acetamidoethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -93.679; CKQYFZPCICOPMQ; [M+H]+; Ambcb4033710
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -100.803; FFJLSBFLTYYWII; [M+H]+; ACMC-20anih
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -111.581; JNTNNUXPPZAEFD; [M+H]+; N-propylformic hydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -112.146; WCVPFJVXEXJFLB; [M+H]+; GABA amide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -112.369; PLNNJQXIITYYTN; [M+H]+; Isobutyrohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -113.068; LZMATGARSSLFMQ; [M+H]+; Isopropyl-urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -113.502; HNNJFUDLLWOVKZ; [M+H]+; 2-aminobutanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.625; QCQZFSUBYDWVBG; [M+H]+; 2-amino-N-ethylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -118.415; FCCCRBDJBTVFSJ; [M+H]+; butanehydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -118.734; SZOHWYCBDJPVGO; [M+H]+; Azoxyaethan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -120.697; ZQZJKHIIQFPZCS; [M+H]+; Propylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -121.924; IABRWXCXQSTUSS; [M+H]+; 1-Ethyl-3-methylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -127.207; BFJOJIJWHRDGQO; [M+H]+; 3-amino-N-methylpropanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -138.411; COSWCAGTKRUTQV; [M+H]+; ACMC-20ajcv
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.469; ODANWMOQWMHGCY; [M+H]+; 13123-70-1 (Parent)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.202; JHRDEHLFNLLCQS; [M+H]+; Isobutyramidoxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -172.392; MKQLBNJQQZRQJU; [M+H]+; 4-Morpholinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.133; YNHNXXYVCYCNJQ; [M+H]+; 1,4,5-oxadiazepane
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.332; WKJOQYHMXRVQDK; [M+H]+; 2-dimethylaminoacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -40.855; WBNQDOYYEUMPFS; [M+H]+; diethyl(nitroso)amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -57.319; SZOHWYCBDJPVGO; [M+H]+; Azoxyethane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -78.822; KNVRBEGQERGQRP; [M+H]+; 2-amino-N,N-dimethylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -81.780; KQDYNYCCEGQPTN; [M+H]+; N-Methyl-N-nitroso-2-propanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -82.816; ITBDKUCVKYSWMF; [M+H]+; Methylpropylnitrosamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -84.165; WKJOQYHMXRVQDK; [M+H]+; 2-(dimethylamino)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -94.500; NODGJSNKUCVLNN; [M+H]+; 2-Hydroxy-N-methyl-2-(methylimino)ethan-1-aminium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -107.968; IABRWXCXQSTUSS; [M+H]+; [Ethylamino(hydroxy)methylidene]-methylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.058; UIWVQFSAXYWENY; [M+H]+; Acetic acid, 2-ethylhydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -118.828; SLIKWWJXVUHCPJ; [M+H]+; Acetamido(dimethyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.688; WBNQDOYYEUMPFS; [M+H]+; diethyl(nitroso)amine
COMMENT: CONFIDENCE Level 3: Tentative candidate, N-nitrosodiethylamine, WBNQDOYYEUMPFS-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (4), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (1);
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C4H10N2O
CH$EXACT_MASS: 102.079313
CH$SMILES: CCN(CC)N=O
CH$IUPAC: InChI=1S/C4H10N2O/c1-3-6(4-2)5-7/h3-4H2,1-2H3
CH$LINK: CHEBI CHEBI:34873
CH$NAME: N-Nitrosodiethylamine
CH$NAME: N-nitrosodiethylamine
CH$NAME: N,N-diethylnitrous amide
CH$LINK: INCHIKEY WBNQDOYYEUMPFS-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:5921
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.734
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 103.086566
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-5900000000-8eaf18ae6a737f57cdef
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0544766 7.8128 55.055184 0.9445 2.35 -0.2147 16 f{C4H7}/4.54ppm,p-H4N2O1
  57.0701341 25.3204 57.070851 0.6834 13.19 -0.2500 16 f{C4H9}/4.51ppm,p-H2N2O1
  58.0653735 151.8849 58.066094 0.1894 9.15 0.7765 16 f{C3H8N1}/4.27ppm,p-C1H3N1O1
  59.0687261 4.2768 59.069450 1.4051 0.76 0.5385 13 ?
  72.0445265 38.5744 72.045269 0.4719 5.22 0.2676 16 f{C3H6N1O1}/1.89ppm,p-C1H5N1
  72.0808858 51.4482 72.081629 0.3746 5.03 0.6088 16 f{C4H10N1}/1.53ppm,p-H1N1O1
  74.0601620 6.0161 74.060903 1.0802 1.36 0.1500 15 f{C3H8N1O1}/1.64ppm,p-C1H3N1
  74.0965356 298.9323 74.097277 0.3239 11.66 0.7765 16 ?
  75.0998360 11.8216 75.100576 1.1185 1.79 0.3321 15 ?
  84.9597395 8.2790 84.960451 1.0829 1.60 -0.2941 16 ?
  85.0283842 6.0602 85.029096 0.6468 2.79 -0.1648 14 ?
  102.1277782 999.0000 102.128371 0.3231 0.00 0.8176 16 ?
  103.1310116 65.8612 103.131595 0.4848 5.19 1.0000 16 ?
  104.1069910 8.6369 104.107565 1.1431 2.70 0.4571 15 ?
PK$NUM_PEAK: 14
PK$PEAK: m/z int. rel.int.
  55.054477 7.81 7
  57.070134 25.32 25
  58.065373 151.88 151
  59.068726 4.28 4
  72.044527 38.57 38
  72.080886 51.45 51
  74.060162 6.02 6
  74.096536 298.93 298
  75.099836 11.82 11
  84.959740 8.28 8
  85.028384 6.06 6
  102.127778 999.00 999
  103.131012 65.86 65
  104.106991 8.64 8
//
